Immune & Thymic · Research deep dive
Thymosin α1: the cited literature
Every study referenced in the Thymosin α1 monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Thymosin α1 is studied at 1.6 mg – 3.2 mg per administration, typically twice weekly. The reference walkthrough below maps each citation to what it actually showed.
References covered
Thymosin alpha 1: past clinical experience and future paradigms
Ann. NY Acad. Sci., 2010
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Thymosin α1.